A61K 49/0034
Indocyanine green, i.e. icg, cardiogreen
Official title: {Indocyanine green, i.e. ICG, cardiogreen}
A61K49/0034 (Indocyanine green, i.e. icg, cardiogreen) appears on 234 US grants and 429 published applications in this corpus.
Search patents in A61K- Granted patents
- 234
- Published applications
- 429
- Assignees
- 229
- Inventors
- 863
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 2 |
| 2003 | 4 | 7 |
| 2004 | 2 | 3 |
| 2005 | 1 | 6 |
| 2006 | 2 | 5 |
| 2007 | 2 | 8 |
| 2008 | 2 | 11 |
| 2009 | 2 | 10 |
| 2010 | 0 | 9 |
| 2011 | 4 | 18 |
| 2012 | 2 | 8 |
| 2013 | 4 | 21 |
| 2014 | 10 | 20 |
| 2015 | 12 | 25 |
| 2016 | 16 | 30 |
| 2017 | 26 | 28 |
| 2018 | 16 | 23 |
| 2019 | 26 | 25 |
| 2020 | 14 | 25 |
| 2021 | 18 | 30 |
| 2022 | 11 | 20 |
| 2023 | 16 | 30 |
| 2024 | 16 | 34 |
| 2025 | 10 | 19 |
| 2026 | 5 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and materials for tissue ablation23 Jun 2026US 12,661,404 B2Mayo Foundation for Medical Education and Research
- Methods of applying preparations of dyes and hydrogels to a tissue26 May 2026US 12,636,383 B2
- Mapping nanoparticles14 Apr 2026US 12,599,683 B2Ferronova Pty Ltd
- Devices, systems, and methods for tumor visualization and removal17 Mar 2026US 12,575,735 B2Sbi Alapharma Canada, Inc.
- Cyanine-based telodendrimers and uses for treating cancer20 Jan 2026US 12,527,880 B2The Regents of the University of California
- Nanostructure Enhanced Targeting (NSET) of Inflammatory Cells30 Jul 2026US 2026/0216076 A1Northwestern University
- Compositions and methods for targeting and treating tumor30 Jul 2026US 2026/0216335 A1Jiangsu Code Biomedical Technology Co., Ltd.
- Conjugates having antifouling nanoparticles and methods of use9 Jul 2026US 2026/0191997 A1Board of Regents, The University of Texas System
- Icg lipid derivative, and lipid microparticles each containing same30 Apr 2026US 2026/0117071 A1Eisai R&D Management Co., Ltd.
- Uses of psma-targeting and tspo-targeting compounds for evaluation of injuries in the peripheral nervous system23 Apr 2026US 2026/0108637 A1
Most cited
By later US patents
- Devices and methods for monitoring drug therapy compliance214US 6,663,846 B12003
- Compounds106US 6,350,431 B1Nycomed Imaging AS · 2002
- Light imaging contrast agents83US 6,540,981 B2Amersham Health AS · 2003
- Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation75US 6,351,663 B1Akorn, Inc. · 2002
- Use of acousto-optical and sonoluminescene contrast agents74US 6,424,857 B1Amersham Health AS · 2002